Objective: Delayed heart rate (HR) recovery in the immediate postexercise period has been linked to adverse cardiovascular prognosis. The after effects of an acute bout of exercise on HR modulation in postmenopausal women (PMW) and the influence of estrogen therapy are unknown.
F luctuations in heart rate (HR) reflect autonomic modulation of sino-atrial discharge. 1, 2 In cardiovascular disease, diminished HR variability (HRV) usually reflects increased sympathetic and decreased vagal tonic HR modulation. These autonomic perturbations have been associated with increased risk for adverse cardiovascular events and mortality even in asymptomatic individuals. 3, 4 Exercise has profound and complex effects on autonomic HR modulation. 5 Importantly, these effects depend on the temporal relationship to exercise and the cumulative effects of exercise training on autonomic tone. For example, increased cardiac sympathetic tone and coincident parasympathetic withdrawal occur during acute exercise. 5, 6 An increased risk of death during and immediately after exercise has been attributed in part to both the magnitude and the subsequent rate of restoration of normal autonomic balance. 7 In direct contrast to these acute effects of exercise, regular aerobic exercise training is cardioprotective, and is associated independently with a reduction in cardiovascular events and total mortality. 8 These benefits include an increased predominance of parasympathetic HR modulation in the exercise trained versus the untrained state. 9, 10 Potentially adverse changes in neural modulation of HR have been shown to occur after both natural 11, 12 and surgical 13 menopause, thus suggesting that endogenous estrogen deficiency may be a factor contributing to a decrease in HRV after menopausal transition. Regular exercise is recommended as a nonpharmacological intervention to reduce cardiovascular risk and to improve cardiovascular risk factor profile in postmenopausal women (PMW). 14, 15 One mechanism contributing to the cardioprotective benefit of exercise in this population may be an enhancement of parasympathetic HR modulation in the physically trained state. 16, 17 Several of the cardiovascular benefits associated with exercise training may be induced rapidly, possibly after a single bout of exercise. 18 In this regard, we have demonstrated previously a reduction in blood pressure (BP) and an improvement in endothelial-dependent flow-mediated dilation in PMW when measured 1 hour after treadmill exercise for 45 minutes, at 60% of peak oxygen consumption (VO 2 peak). 19, 20 To our knowledge, the pattern and rate of HRV recovery in healthy sedentary PMW after a single bout of submaximal aerobic exercise have not been reported, but may be of clinical relevance, given the contrasting immediate versus delayed effects of exercise on autonomic modulation. Furthermore, whether HRV recovery after exercise in this population is influenced by treatment with estrogen is unknown. Thus, this study in sedentary PMW was designed to determine, using frequency domain HRV analysis, the pattern and degree of recovery of tonic autonomic HR modulation measured 60 minutes after a single bout of submaximal dynamic exercise of a type and intensity commonly prescribed to enhance cardiovascular health; and whether autonomic modulation after exercise is influenced by concurrent administration of oral estrogen. To characterize the after effects of exercise on autonomic modulation in a comparator group of healthy younger estrogen-replete women, normotensive premenopausal women (PreM) were submitted to the identical protocol.
METHODS

Participants
We have previously reported the relationship between estrogen therapy, BP, and vascular function, both before and after an acute bout of dynamic exercise, in these PreM and PMW. 19, 20 However, thus far, we have not evaluated the effects of an acute bout of exercise on their HRV. PMW (n ¼ 13) were deemed healthy as determined by medical history, physical examination, and screening hematologic and biochemical testing performed before study entry. All were sedentary (no more than 2 h/wk of physical activity for at least the previous 6 mo), normotensive (seated clinic BP [BP] of 140/90 mm Hg), nondiabetic, nonsmokers, and on no medications. To be eligible, participants reported at least 12 months of amenorrhea with the uterus intact or a previous hysterectomy. Biochemical evidence (serum follicle-stimulating hormone concentration [FSH] of !20 IU/L) confirmed the menopause status. No woman received hormone therapy (HT) for at least 2 months before study entry.
To obtain reference HRV values to compare with PMW, 14 healthy PreM were also investigated under identical experimental conditions. All PreM described regular menstrual cycles, averaging 25 to 35 days. None were receiving any oral contraceptive formulations. PreM were studied during the follicular phase (estrogen relatively unopposed by progesterone) between days 5 and 13 of the menstrual cycle. Pregnancy was excluded by a negative b-human chorionic gonadotropin test.
The protocol was approved by our institutional Human Ethics Review Committee, and all participants provided signed written consent.
Protocol
All experiments were conducted at the Clinical Cardiovascular Physiology Laboratory of the Toronto General Hospital in the morning, at a stable temperature between 228C and 248C. All participants were fasted overnight and avoided exercise, alcohol, and caffeine over the 24 hours before the study. Participants lay in the supine position. An antecubital vein was cannulated for blood sampling. HR was determined from lead II of an electrocardiogram recorded continuously throughout the study. Arterial BP was measured noninvasively at 1-minute intervals from the left arm by an automatic cuff recorder (Dinamap Pro 100, Critikon LLC, Tampa, FL). A respiratory belt encircled the upper abdomen.
After 10 minutes of quiet supine rest in a semidark ambienttemperature room, baseline BP and HR were acquired during 7 minutes of spontaneous breathing. All participants were then exercised on a treadmill for a total of 45 minutes. To provide similar exercise loads, the speed and grade of treadmill exercise were adjusted to maintain a target HR recorded during exercise at 60% of each individual's peak oxygen consumption (VO 2 peak), as measured during a graded exercise test performed on a separate day. After exercise, participants resumed the resting supine position. Postexercise measurements commenced at 60 minutes after exercise. In PMW, this protocol was replicated 4 weeks after treatment with open-labeled oral estradiol (2 mg/d). Participants were instructed to take this estrogen formulation at approximately the same time each morning, with the exception of the study day. After completion of the study protocol, PMW with a uterus in situ were prescribed medroxyprogesterone acetate 10-mg tablets once daily for a period of 12 days to convert the endometrium from the follicular to the secretory state.
Heart rate variability
Our approach to frequency domain analysis of HRV has been previously described. 21 Briefly, during spontaneous breathing, the ECG signal was sampled at 1000 Hz and was stored using LabView (National Instruments, Austin, TX) for subsequent analysis. R-R intervals were analyzed using fast Fourier transformation (FFT) to produce a spectral density curve showing a plot of the frequency of the cyclic components of variation in the R-R interval duration against the square root of their amplitude. A 7-minute data set comprising 2,048 data points was collected and subsequently divided into seven segments, each containing 512 points, with one-half overlapping of each segment. The linear trend in the data was subtracted from the data set in each segment, and a Blackman-Harris window was applied to minimize the spectral leakage. Power spectra were obtained over a frequency range of 0.0098 to 0.5 Hz, permitting the report of power spectra across very low frequency (VLF: 0.0098-0.05 Hz), low frequency (LF: a composite of both sympathetic and parasympathetic modulation, 0.05-0.15 Hz), and high frequency (HF: an index of parasympathetic modulation, 0.15-0.5 Hz). Frequency domains were determined in absolute units (ms 2 ) and with log 10 transformation. For all data sets, only stationary time series with 5% or less arrhythmia or artefact were used for analyses. Using the same protocol as described herein, our group has reported excellent stability in same-day 22 and between-day 23 recordings of HRV.
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Peak aerobic consumption
On a separate day, peak oxygen consumption (VO 2 peak) was measured directly by open-circuit spirometry during a standard graded cardiopulmonary exercise stress test.
Blood sampling
Blood was collected from participants at baseline before exercise in PreM and in PMW on both study days. Serum concentrations of FSH and 17b-estradiol were analyzed using commercially available radioimmunoassay kits (Boehringer, Mannheim, Germany).
Statistical analysis
All variables are expressed as mean AE standard error of the mean (SEM). All baseline HRV absolute data variables demonstrated a positively skewed distribution. Consequently, VLF, LF, and HF were log-transformed (log10) to minimize the variance and normalize the distribution. For PMW, the average values at each phase of the study were compared by a two-factor repeated-measures analysis of variance (ANOVA) (SPSS version 22.0; SPSS Inc, Chicago, IL) with estrogen and exercise as within-participant factors. The Student-Newman-Keuls method was used for pairwise, post hoc, multiple comparisons. In PreM, paired t tests were used to compare differences before and after exercise. The Student's t test was used for unpaired observations (PreM vs PMW). All statistical tests were two-tailed with P less than 0.05 considered as the threshold for significance.
RESULTS
Participants
Baseline physical characteristics of PMW were: mean age 54 AE 2 years, body mass index (BMI) 28.6 AE 1.5 kg/m 2 , and mean VO 2 peak 1.33 AE 0.01 L/min. 19, 20 For PreM, mean age was 28 AE 1 years, and mean BMI was 22 AE 1 kg/m 2 . Mean VO 2 peak for this group was 1.89 AE 0.02 L/min. These VO2peak values were 73% and 85% of predicted, respect-ively. 24 Each of these characteristics were significantly different (P < 0.05) between the groups.
Blood sampling
As expected, baseline pre-estrogen serum measures of 17b-estradiol in PMW were lower (P < 0.001) compared with postestrogen (22 AE 3.3 vs 998 AE 220 pmol/L, respectively). 19, 20 FSH (IU/L) was significantly reduced (P < 0.001) by estrogen therapy (78 AE 3 vs 37 AE 6, pre vs postestrogen, respectively). In the premenopausal group, mean serum estradiol measured in the follicular phase was 187 AE 28 pmol/L.
Resting heart rate and arterial pressure
The BP and HR values of PMW are given in Table 1 . With estrogen resting, systolic BP (SBP) was unchanged, but diastolic BP (DBP) and mean arterial pressure (MAP) were lower (P < 0.01). Despite these changes, there were no significant differences between pre-estrogen and postestrogen baseline resting values for HR. Resting HR and BP values of PreM and PMW were similar (P > 0.05).
Resting heart rate variability
Baseline frequency domain measures of HRV in PMW before and after estrogen therapy are shown in Table 1 . At rest, PMW demonstrated similar LF compared with PreM both before and after the estrogen therapy. In contrast, resting HF was lower (P < 0.05) in PMW both before and after estrogen therapy when compared with PreM.
Exercise
All participants completed the full 45-minute exercise protocol. In PMW, HRs achieved during exercise were 116 AE 4 and 114 AE 3 beats/min before and after estrogen therapy, respectively. 19, 20 These values corresponded to 101% AE 1% and 100% AE 1% of the target exercise HR. PreM achieved mean HR of 128 AE 3 beats/min, which corresponded All values are mean AE SEM. DBP, diastolic blood pressure; HF, high-frequency power spectra; HR, heart rate; LF, low-frequency power spectra; log 10 , log 10 transformed data; MAP, mean arterial pressure; mm Hg, millimetres of mercury; PMW, postmenopausal women; Pre Ex, pre-exercise; PreM, premenopausal women; Post Ex, postexercise; SBP, systolic blood pressure; VLF, very low frequency power spectra. a P < 0.05 vs pre-exercise, within groups. b P < 0.05 vs PMW pre-exercise, pre-estrogen. to 100 AE 2% of the target exercise HR. Exercise increased SBP by 17 AE 3 mm Hg before estrogen as compared with 9 AE 4 mm Hg after estrogen (P ¼ 0.12). Exercise increased average SBP by 10 AE 4 mm Hg in the premenopausal group (P ¼ 0.15 premenopausal vs postmenopausal pre-estrogen).
After-exercise heart rate and arterial pressure One hour after exercise, in PMW, SBP and DBP were lower (P < 0.05) both before and after estrogen therapy (Table 1) . One hour after exercise, in PreM, SBP and DBP were unchanged (P > 0.05). HR after exercise was elevated (P > 0.05) and identical in both the groups. 19, 20 After-exercise heart rate variability
In PMW, two-way ANOVA identified that exercise significantly lowered all indices of HRV, except LF/HF, which remained unaltered (P > 0.05; Table 1 ). In contrast, no significant main effect for estrogen therapy was detected. After exercise, in PMW, pre-estrogen therapy demonstrated lower (P < 0.05) LF, HF, and total HRV compared with that in PreM (Table 1) . Estrogen therapy did not alter (P > 0.05) resting or postexercise frequency domain measures of HRV. In PreM, 1 hour after exercise, despite a similar HR, all HRV measures were unchanged from pre-exercise values (P > 0.05).
DISCUSSION
This study had two aims. The first aim was to compare the after effects of a single bout of dynamic exercise on cardiac autonomic HR modulation assessed by frequency domain analysis of HRV in healthy sedentary PreM and PMW. The second was to investigate the influence of exogenous estrogen on the postexercise HRV responses in PMW. Consistent with the previous literature, 11, 17, 25, 26 HF spectral power-an index of parasympathetic modulation of HRwas lower at rest in PMW compared with PreM. Our key new findings were as follows: in healthy sedentary PreM, frequency-domain indexes of HR modulation recorded 1 hour after submaximal dynamic exercise were not significantly reduced from the pre-exercise values. In contrast to these findings in PreM, in PMW, HF and LF remained suppressed below pre-exercise values at 1 hour after acute exercise, and pretreatment with chronic oral estrogen did not augment vagal modulation at rest, or enhance HRV recovery in the postexercise period, suggesting delayed recovery of autonomic modulation. In view of the recent concerns that these indices of HRV are simply a function of HR, 27 it is important to emphasize that these differences between PreM and PMW occurred despite identical HRs after exercise.
The present finding of attenuated HF power-an index of parasympathetic modulation of HR-in PMW at baseline rest when compared with a comparator group of PreM is concordant with that of other investigators who have shown reductions in HRV in women after both natural 11, 16, 25, 26 and surgical 13 menopause. However, both aging and postmenopausal hormonal deficiency may contribute to changes in autonomic HR modulation in the postmenopausal period.
We did not show any significant influence on resting HR or augmentation of resting HRV in our PMW after administration of oral estrogen, suggesting that the difference in HRV observed between PreM and PMW may be more consistent with aging than estrogen deficiency.
Previous studies of the effects of exogenous estrogen on resting cardiac autonomic HR modulation in PMW have yielded inconsistent results. In some studies, exogenous estrogen has been shown to attenuate, although not necessarily fully reverse, menopause-associated decreases in HRV through enhancement of cardiac vagal and attenuation of cardiac sympathetic tone, 11, 13, 25, 26 whereas other studies have been unable to replicate this finding. 28, 29 These inconsistencies may reflect differences in participant baseline characteristics, in the type, dose, mode of administration, and timing of exogenous estrogen, and in the experimental condition. For example, Neves et al 26 found that estrogen partially alleviated the decline in HRV in their PMW, but only when acquired in the seated and not in the supine position.
Importantly, these previous investigators determined HRV in PMW before and after estrogen therapy, only under resting conditions. Little is known of the influence of exogenous estrogen on HRV after different stimuli known to influence autonomic HR regulation. For the purpose of this analysis, we were particularly interested in the after effects of a single bout of dynamic exercise. Exercise has complex effects on sympathovagal HR modulation. Regular physical activity is associated with increased HRV and in particular a shift towards enhanced parasympathetic modulation. These changes are believed to contribute to improved cardiac electrical stability, and thus to the well documented cardioprotective benefits of exercise training. 9, 10 However, in contrast to these well recognized cardioprotective effects of regular physical activity, risk of sudden cardiac death is increased during and immediately after exercise. 7, 30 It is generally agreed that during exercise, there is parasympathetic withdrawal and sympathetic excitation. 5, 6 Delayed HR recovery in the immediate postexercise period is postulated to reflect delayed parasympathetic recovery and has been shown to be a predictor of sudden cardiac death. However, data pertaining to the kinetics of recovery of autonomic function after cessation of exercise beyond the very immediate postexercise period are much less well explored, and the timing and pattern of the recovery of autonomic regulation back to baseline is debated. 6, 18, 31 Of the relatively small number of studies examining the delayed effects of exercise on autonomic modulation as measured by HRV, the majority have been undertaken in young men. It is unclear whether parasympathetic withdrawal or alternatively sympathetic withdrawal predominates in the delayed postexercise period in these studies. Intensity and type of exercise (eg, interval vs constant vs resistance), timing, and position of the participant during acquisition of recordings after exercise vary between these studies and likely contribute to the heterogeneous findings in otherwise similar young male cohorts. 6, 18, [32] [33] [34] [35] [36] [37] 
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There is no present published literature concerning HRV responses 1 hour after exercise in either healthy untrained PreM or PMW. Figueroa et al 38 compared HRV at 20 minutes after walking exercise at 65% VO 2 peak in lean (n ¼ 8) and obese (n ¼ 8) middle-aged women (40-60 y) with type 2 diabetes, and 12 obese women without type 2 diabetes. These investigators reported suppressed HF, more marked in the obese and diabetic than in the lean and diabetic participants, after exercise. More delayed postexercise responses were not studied, nor were women defined by menopause status. We found no delayed postexercise effect on HRV in our PreM, but our PMW had persistently depressed HF and total HRV values at 1 hour after acute submaximal walking exercise. Although we excluded participants with glucose intolerance, hyperlipidemia, and hypertension, it is possible that the higher BMI and lower cardiorespiratory fitness of our PMW compared with PreM contributed to the observed attenuated return of postexercise HF to pre-exercise values. In support of this concept, previous studies report that elevated BMI is inversely and cardiorespiratory fitness positively associated with HRV. 39, 40 
Limitations
We did not record HR during controlled breathing, but it has been demonstrated previously in middle-aged volunteers studied supine that paced and spontaneous breathing provides similar information if recording periods are short and if spontaneous breaths fall within the HF band, 41 as it was in our participants both before and after exercise.
CONCLUSIONS
In summary, we have shown that in sedentary PreM, HRV power spectra density recovers to pre-exercise values when measured an hour after a single bout of treadmill exercise performed at a submaximal intensity that is comparable to prescriptions recommended for maintenance of cardiovascular health. In contrast, PMW exhibit significant reductions in HF, LF, and total HRV spectral power after exercise. This sustained attenuation, particularly of tonic vagal HR modulation, is not an artefact of HR, since HRs after exercise were similar in the PreM and PMW. Four weeks of estrogen replacement did not increase resting HRV and did not accelerate postexercise HRV recovery in PMW. These observations suggest aging and mechanisms consequent to the accretion of other age-related changes, such as a high BMI and low cardiorespiratory fitness, contribute to the lower resting HRV and delayed HRV recovery 1 hour after exercise in our PMW.
Low resting HRV is a recognized marker of adverse prognosis in cardiac women and healthy populations. 3, 4 During, and recovery from, exercise is suggested to be a vulnerable window for dysrhythmias and fatal events. 42 Autonomic evaluation of PMW during recovery from exercise may therefore also be of prognostic importance, particularly in the light of current directives to actively encourage this population to engage in physical activity as part of a healthy lifestyle. 14, 15 Thus, delineation of the additional information that could be yielded from postexercise recovery of HRV in response to both acute and chronic exercise training, and how estrogen influences this process, is of significance to PMW. Understanding the short and long-term effects of exercise on the cardiac autonomic nervous system will provide insight into whether regular physical activity and improved fitness can, over time, positively influence the postexercise recovery of vagal HR modulation of PMW.
